$OPK
OPKO HEALTH, INC.

2014 Q4 Form 10-Q Financial Statement

#000094480914000014 Filed on November 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $25.53M $19.77M $20.64M
YoY Change 23.4% -4.21% 75.0%
Cost Of Revenue $11.90M $11.12M $11.95M
YoY Change -0.83% -6.96% 59.64%
Gross Profit $13.60M $8.653M $39.65M
YoY Change -75.95% -78.18% 87.36%
Gross Profit Margin 53.26% 43.76% 192.09%
Selling, General & Admin $15.20M $14.01M $13.57M
YoY Change -1.3% 3.23% 85.36%
% of Gross Profit 111.76% 161.91% 34.23%
Research & Development $27.80M $20.52M $11.09M
YoY Change 18.8% 85.09% 206.13%
% of Gross Profit 204.41% 237.11% 27.96%
Depreciation & Amortization $3.600M $3.768M $3.768M
YoY Change -21.74% 0.0% 41.39%
% of Gross Profit 26.47% 43.55% 9.5%
Operating Expenses $57.99M $67.97M $39.65M
YoY Change 2.53% 71.44% 87.35%
Operating Profit -$44.39M -$48.20M -$19.01M
YoY Change 153.56% 97.08%
Interest Expense -$15.80M $1.300M -$40.80M
YoY Change 1336.36% -103.19% 13500.0%
% of Operating Profit
Other Income/Expense, Net -$5.100M -$1.459M -$38.90M
YoY Change -122.57% -96.25% 32317.5%
Pretax Income -$53.30M -$49.66M -$57.91M
YoY Change 270.14% -14.25% 510.3%
Income Tax -$1.000M $294.0K $1.290M
% Of Pretax Income
Net Earnings -$53.46M -$48.67M -$60.00M
YoY Change 206.74% -18.88% 522.0%
Net Earnings / Revenue -209.38% -246.14% -290.67%
Basic Earnings Per Share -$0.12 -$0.11
Diluted Earnings Per Share -$0.12 -$0.11 -$166.4K
COMMON SHARES
Basic Shares Outstanding 434.1M shares 427.6M shares 336.8M shares
Diluted Shares Outstanding 427.6M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $96.90M $118.3M $180.8M
YoY Change -47.85% -34.57% 326.42%
Cash & Equivalents $96.91M $118.3M $155.8M
Short-Term Investments $25.00M
Other Short-Term Assets $4.212M $2.591M $4.304M
YoY Change -25.49% -39.8% -13.92%
Inventory $16.60M $16.66M $19.52M
Prepaid Expenses
Receivables $19.97M $21.21M $21.37M
Other Receivables $3.100M $1.900M $6.800M
Total Short-Term Assets $142.9M $163.1M $241.3M
YoY Change -41.14% -32.38% 174.18%
LONG-TERM ASSETS
Property, Plant & Equipment $16.41M $17.04M $17.03M
YoY Change -3.62% 0.05% 33.02%
Goodwill $224.3M $224.8M $222.3M
YoY Change -0.92% 1.09%
Intangibles
YoY Change
Long-Term Investments $16.10M $21.10M $23.10M
YoY Change -47.56% -8.66% 54.0%
Other Assets $5.838M $4.673M $7.003M
YoY Change -14.91% -33.27% 268.58%
Total Long-Term Assets $1.125B $1.132B $1.142B
YoY Change -2.09% -0.84% 604.76%
TOTAL ASSETS
Total Short-Term Assets $142.9M $163.1M $241.3M
Total Long-Term Assets $1.125B $1.132B $1.142B
Total Assets $1.268B $1.295B $1.383B
YoY Change -8.9% -6.34% 453.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.744M $8.841M $13.63M
YoY Change -34.81% -35.14% 89.32%
Accrued Expenses $60.91M $55.55M $43.27M
YoY Change -7.53% 28.39% 98.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $13.46M $12.45M $14.48M
YoY Change 7.11% -14.03% -16.8%
Total Short-Term Liabilities $83.11M $76.84M $71.38M
YoY Change -9.51% 7.66% 53.83%
LONG-TERM LIABILITIES
Long-Term Debt $2.434M $2.627M $3.350M
YoY Change -25.57% -21.58% -16.25%
Other Long-Term Liabilities $50.21M $216.2M $234.8M
YoY Change -76.62% -7.92% 1197.03%
Total Long-Term Liabilities $348.8M $331.1M $443.7M
YoY Change -18.25% -25.38% 1907.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $83.11M $76.84M $71.38M
Total Long-Term Liabilities $348.8M $331.1M $443.7M
Total Liabilities $431.9M $407.9M $515.1M
YoY Change -16.7% -20.81% 548.69%
SHAREHOLDERS EQUITY
Retained Earnings -$674.8M -$621.9M -$486.4M
YoY Change 34.12% 27.86%
Common Stock $4.334M $4.329M $4.089M
YoY Change 4.48% 5.87%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.051M $4.051M $7.457M
YoY Change -44.97% -45.68%
Treasury Stock Shares 1.245M shares 1.245M shares 2.293M shares
Shareholders Equity $842.1M $893.3M $870.7M
YoY Change
Total Liabilities & Shareholders Equity $1.268B $1.295B $1.383B
YoY Change -8.9% -6.34% 453.19%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$53.46M -$48.67M -$60.00M
YoY Change 206.74% -18.88% 522.0%
Depreciation, Depletion And Amortization $3.600M $3.768M $3.768M
YoY Change -21.74% 0.0% 41.39%
Cash From Operating Activities -$24.80M -$21.10M -$8.900M
YoY Change -4.98% 137.08% 368.42%
INVESTING ACTIVITIES
Capital Expenditures -$800.0K -$1.400M -$900.0K
YoY Change -20.0% 55.56% 28.57%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $46.20M
YoY Change -100.0% -100.0% -557.43%
Cash From Investing Activities -$800.0K -$1.600M $45.20M
YoY Change -102.06% -103.54% -518.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.200M 7.100M 300.0K
YoY Change -75.29% 2266.67% -116.67%
NET CHANGE
Cash From Operating Activities -24.80M -21.10M -8.900M
Cash From Investing Activities -800.0K -1.600M 45.20M
Cash From Financing Activities 4.200M 7.100M 300.0K
Net Change In Cash -21.40M -15.60M 36.60M
YoY Change -171.81% -142.62% -352.41%
FREE CASH FLOW
Cash From Operating Activities -$24.80M -$21.10M -$8.900M
Capital Expenditures -$800.0K -$1.400M -$900.0K
Free Cash Flow -$24.00M -$19.70M -$8.000M
YoY Change -4.38% 146.25% 566.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
565000 USD
CY2013Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1985000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13414000 USD
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8841000 USD
CY2013Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
21652000 USD
CY2014Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
22642000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21210000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19767000 USD
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4399000 USD
CY2014Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
5614000 USD
CY2014Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
325000 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
702000 USD
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
55554000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65874000 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
402000 USD
CY2014Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
766000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3418000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8697000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1379383000 USD
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1523548000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1885000 USD
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1432000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1907000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
993000 USD
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2790000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8304000 USD
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2735000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8192000 USD
CY2013Q4 us-gaap Assets
Assets
1391516000 USD
CY2014Q3 us-gaap Assets
Assets
1295242000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
163148000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
242728000 USD
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
12062000 USD
CY2014Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
13291000 USD
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
4301000 USD
CY2014Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
12904000 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
1300000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-121176000 USD
CY2014Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-50014000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
130118000 USD
CY2013Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-75858000 USD
CY2014Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
19773000 USD
CY2013Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
20641000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
75838000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
65592000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
24078000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4173000 USD
CY2013Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
252000 USD
CY2014Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19592000 USD
CY2013Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
71600000 USD
CY2014Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
71200000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
185798000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118258000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27361000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155834000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-67540000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
128473000 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11269000 USD
CY2014Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3678000 USD
CY2013Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3768000 USD
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
414818195 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
432895788 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
4148000 USD
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
4329000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-102146000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-130810000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57672000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59591000 USD
CY2013Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
211912000 USD
CY2014Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
114883000 USD
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11952000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
36075000 USD
CY2014Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11120000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
36812000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-197000 USD
CY2013Q4 us-gaap Deferred Revenue
DeferredRevenue
8300000 USD
CY2014Q3 us-gaap Deferred Revenue
DeferredRevenue
7700000 USD
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5147000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7639000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
166435000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
164512000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10648000 USD
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
34000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-180000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3847
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
3300000 USD
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
127800000 USD
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
-18800000 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
31300000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24403000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31527000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
74533000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
65553000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1409000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1008000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3758000 USD
CY2014Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3305000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-48351000 USD
CY2013Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-37453000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
10953000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
1273000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-56000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2668000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
972000 USD
CY2014Q3 us-gaap Goodwill
Goodwill
224769000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
226373000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Other Changes
GoodwillOtherChanges
-1604000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-89797000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-117681000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-49660000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-57911000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-50014000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-60801000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-99916000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-121176000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2486000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7861000 USD
CY2013Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1600000 USD
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-60000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1009000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2258000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1290000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
294000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
566000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
316000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3850000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2303000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
724000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4140000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9467000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1666000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-952000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1099000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-525000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4465000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3487000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2081000 USD
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
793341000 USD
CY2014Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
793214000 USD
us-gaap Interest Paid
InterestPaid
3126000 USD
us-gaap Interest Paid
InterestPaid
5222000 USD
CY2014Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11355000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13374000 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
16662000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
18079000 USD
CY2014Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4859000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4132000 USD
CY2014Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
592000 USD
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
777000 USD
CY2014Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1040000 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1350000 USD
us-gaap Inventory Write Down
InventoryWriteDown
1529000 USD
us-gaap Inventory Write Down
InventoryWriteDown
773000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
407898000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
518537000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1391516000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1295242000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91850000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
76841000 USD
CY2013Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
426687000 USD
CY2014Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
331057000 USD
CY2013Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
9061000 USD
CY2014Q3 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
7761000 USD
CY2014Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
13151000 USD
CY2014Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
12446000 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
12562000 USD
CY2014Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2627000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3270000 USD
CY2014Q3 us-gaap Long Term Investments
LongTermInvestments
26849000 USD
CY2013Q4 us-gaap Long Term Investments
LongTermInvestments
30653000 USD
CY2014Q3 us-gaap Minority Interest
MinorityInterest
-5913000 USD
CY2013Q4 us-gaap Minority Interest
MinorityInterest
-3431000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
166598000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3134000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4876000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8556000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65618000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29603000 USD
us-gaap Net Income Loss
NetIncomeLoss
-97607000 USD
us-gaap Net Income Loss
NetIncomeLoss
-118695000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-48669000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-59998000 USD
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-803000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2309000 USD
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1345000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2481000 USD
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-59998000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-118695000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-98027000 USD
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-48669000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1459000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-46031000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4320000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-38901000 USD
CY2013Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6151000 USD
CY2014Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
0 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Operating Expenses
OperatingExpenses
119604000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
67974000 USD
us-gaap Operating Expenses
OperatingExpenses
178953000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
39651000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-48201000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-43766000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-19010000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-113361000 USD
CY2014Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12321000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5653000 USD
CY2014Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2591000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4673000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6861000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15878000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-11562000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
367000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1395000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3169000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4781000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12115000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
900000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
4593000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
553000 USD
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
40000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1869000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6781000 USD
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5834000 USD
CY2013Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
1509000 USD
CY2014Q3 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
3658000 USD
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
216174000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
214775000 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1873000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12231000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2764000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2044000 USD
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
0 USD
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
6264000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
4596000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
4250000 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
2539000 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
6435000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-11628000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1331000 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
3015000 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1683000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-20528000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
13341000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
589000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
50027000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3935000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2991000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
420000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
6606000 USD
CY2013Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2014Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7018000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19084000 USD
CY2013Q4 us-gaap Prepaid Insurance
PrepaidInsurance
892000 USD
CY2014Q3 us-gaap Prepaid Insurance
PrepaidInsurance
944000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications and correction of immaterial errors. </font><font style="font-family:inherit;font-size:10pt;">During 2013 and the first quarter of 2014, we reported payments for contingent consideration and some deferred payments as cash outflows from operating activities. Amounts paid pertaining to the initial purchase accounting contingent liabilities should have been classified as cash outflows from financing activities. Amounts paid in excess of the initial purchase accounting contingent liabilities have been classified as cash outflows from operating activities. We have corrected the amounts previously reported in our Form 10-Q for the </font><font style="font-family:inherit;font-size:10pt;">nine months ended September 30, 2013</font><font style="font-family:inherit;font-size:10pt;"> in conjunction with the filing of this Form10-Q and the </font><font style="font-family:inherit;font-size:10pt;">nine months ended September 30, 2014</font><font style="font-family:inherit;font-size:10pt;"> by reducing cash outflows from operating activities&#160;and increasing cash outflows from financing activities by&#160;</font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$6.4 million</font><font style="font-family:inherit;font-size:10pt;"> for 2013 and 2014, respectively. </font></div></div>
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
170184000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
12066000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5061000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
24613000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
19326000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
25016000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
631000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Profit Loss
ProfitLoss
-121176000 USD
us-gaap Profit Loss
ProfitLoss
-99916000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17036000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17027000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-20000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
810000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
553000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
21823000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
27706000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30552000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57744000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20517000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11085000 USD
CY2013Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
10055000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
CY2014Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-621872000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-503177000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
16563000 USD
CY2013Q4 us-gaap Supplies
Supplies
945000 USD
CY2014Q3 us-gaap Supplies
Supplies
1626000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
50708000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
58510000 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
17291000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
65592000 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
20641000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
19773000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
75838000 USD
CY2013Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
2770000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
9050000 USD
CY2014Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
2482000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13572000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39875000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14010000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42697000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10088000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7411000 USD
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3100000 USD
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
400000 USD
CY2014Q3 us-gaap Share Price
SharePrice
0.36
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
876410000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
893257000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
872979000 USD
CY2014Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
887344000 USD
CY2014Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1245367 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2264063 shares
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
7362000 USD
CY2014Q3 us-gaap Treasury Stock Value
TreasuryStockValue
4051000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font><font style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>
CY2014Q3 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
7400000 USD
CY2013Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
6700000 USD
CY2014Q3 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
13100000 USD
CY2013Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
10400000 USD
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
427577102 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
360638527 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
336942515 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
418649421 shares
CY2013Q4 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
3342000 USD
CY2014Q3 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
5524000 USD
CY2014Q3 opk Accumulated Income Loss From Equity Method Investments
AccumulatedIncomeLossFromEquityMethodInvestments
9855000 USD
CY2014Q3 opk Available For Sale Securities Gross Unrealized And Realized Gain Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedAndRealizedGainLossAccumulatedInInvestments
387000 USD
CY2013Q4 opk Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
3739000 USD
CY2014Q3 opk Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
876000 USD
CY2013Q4 opk Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
0 USD
CY2014Q3 opk Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
4551000 USD
CY2013Q4 opk Availablefor Sale Securities Accumulated Gross Realized Gain Loss Net
AvailableforSaleSecuritiesAccumulatedGrossRealizedGainLossNet
4022000 USD
CY2014Q3 opk Availablefor Sale Securities Accumulated Gross Realized Gain Loss Net
AvailableforSaleSecuritiesAccumulatedGrossRealizedGainLossNet
4062000 USD
CY2014Q3 opk Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-0.11
opk Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-0.28
opk Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-0.32
CY2013Q3 opk Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-0.19
CY2014Q3 opk Business Acquisition Pro Forma Net Income Loss Availableto Common Stockholders
BusinessAcquisitionProFormaNetIncomeLossAvailabletoCommonStockholders
-48669000 USD
CY2013Q3 opk Business Acquisition Pro Forma Net Income Loss Availableto Common Stockholders
BusinessAcquisitionProFormaNetIncomeLossAvailabletoCommonStockholders
-75055000 USD
opk Business Acquisition Pro Forma Net Income Loss Availableto Common Stockholders
BusinessAcquisitionProFormaNetIncomeLossAvailabletoCommonStockholders
-118695000 USD
opk Business Acquisition Pro Forma Net Income Loss Availableto Common Stockholders
BusinessAcquisitionProFormaNetIncomeLossAvailabletoCommonStockholders
-128229000 USD
opk Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Discount Rates Increase One Percent
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfDiscountRatesIncreaseOnePercent
1300000 USD
opk Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent
1300000 USD
CY2014Q3 opk Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
25857000 USD
CY2013Q4 opk Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
28047000 USD
CY2014Q3 opk Business Combination Deferred Acquisition Payments Netof Discount Current
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent
0 USD
CY2013Q4 opk Business Combination Deferred Acquisition Payments Netof Discount Current
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent
5465000 USD
CY2013Q4 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
1100000000 USD
CY2014Q3 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
1100000000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
3494000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
815000 USD
CY2013Q4 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
12 institution
CY2014Q3 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
10 institution
CY2013Q3 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-59201000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-118690000 USD
CY2014Q3 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-49954000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-92055000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
10572000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
10148000 USD
CY2014Q3 opk Interest Expense Nonoperating
InterestExpenseNonoperating
2402000 USD
CY2013Q3 opk Interest Expense Nonoperating
InterestExpenseNonoperating
3409000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
450000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
237000 USD
CY2013Q3 opk Interest Income Nonoperating
InterestIncomeNonoperating
88000 USD
CY2014Q3 opk Interest Income Nonoperating
InterestIncomeNonoperating
402000 USD
CY2012Q3 opk Numberof Medicare Claims Includedin Post Payment Review Audit
NumberofMedicareClaimsIncludedinPostPaymentReviewAudit
183 claim
opk Percentage Of Increase Decrease In Discount Rate
PercentageOfIncreaseDecreaseInDiscountRate
0.01
CY2014Q3 opk Percentage Of Increase Decrease In Future Sales
PercentageOfIncreaseDecreaseInFutureSales
0.10
opk Revenue From Receipt Of Equity
RevenueFromReceiptOfEquity
12680000 USD
opk Revenue From Receipt Of Equity
RevenueFromReceiptOfEquity
180000 USD
opk Revenue From Sale Of Intellectual Property
RevenueFromSaleOfIntellectualProperty
0 USD
opk Revenue From Sale Of Intellectual Property
RevenueFromSaleOfIntellectualProperty
12500000 USD
CY2013Q3 opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
1308000 USD
CY2014Q3 opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
0 USD
opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
16080000 USD
opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
476000 USD
CY2014Q3 opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
86 shares
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
395242 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
5262094 shares
CY2014Q3 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
3556688 shares
CY2014Q3 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
3556602 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
4866852 shares
CY2014Q3 opk Taxes Recoverable Current
TaxesRecoverableCurrent
1292000 USD
CY2013Q4 opk Taxes Recoverable Current
TaxesRecoverableCurrent
3458000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000944809
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
434144555 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Opko Health, Inc.

Files In Submission

Name View Source Status
0000944809-14-000014-index-headers.html Edgar Link pending
0000944809-14-000014-index.html Edgar Link pending
0000944809-14-000014.txt Edgar Link pending
0000944809-14-000014-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
opk-20140930.xml Edgar Link completed
opk-20140930.xsd Edgar Link pending
opk-20140930_cal.xml Edgar Link unprocessable
opk-20140930_def.xml Edgar Link unprocessable
opk-20140930_lab.xml Edgar Link unprocessable
opk-20140930_pre.xml Edgar Link unprocessable
opk-9302014x10q.htm Edgar Link pending
opk-9302014xex311.htm Edgar Link pending
opk-9302014xex312.htm Edgar Link pending
opk-9302014xex321.htm Edgar Link pending
opk-9302014xex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending